NKp30 is a functional activation receptor on a subset of rat natural killer cells

European Journal of Immunology

Volumn 36, Issue 8, 2006, Pages 2170-2180

  Hsieh, Christine L ^a   Nagasaki, Kazuhito ^a   Martinez, Olivia M ^a   Krams, Sheri M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell surface; Cellular activation; Immunity; Innate; Molecules; NK cells; Transplantation

Indexed keywords

CELL RECEPTOR; GAMMA INTERFERON; MONOCLONAL ANTIBODY; PROTEIN NKP30; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL; CELL ACTIVATION; CELL ISOLATION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXICITY; FLOW CYTOMETRY; GENETIC TRANSFECTION; IMMUNE RESPONSE; IN VIVO STUDY; LIVER CELL; LIVER TRANSPLANTATION; LYMPHOMA CELL LINE; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SPLEEN CELL; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE; INTERFERON TYPE II; KILLER CELLS, NATURAL; LIVER; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; RATS; RECEPTORS, IMMUNOLOGIC; SPLEEN; TRANSFECTION;

EID: 33747422862     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200635982     Document Type: Article

References (43)

1. Cerwenka, A. and Lanier, L. L., Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 2001. 1: 41-49.
2. Raulet, D. H., Interplay of natural killer cells and their receptors with the adaptive immune response. Nat. Immunol. 2004. 5: 996-1002.
3. Salazar-Mather, T. P., Hamilton, T. A. and Biron, C. A., A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J. Clin. Invest. 2000. 105: 985-993.
4. Obara, H., Nagasaki, K., Hsieh, C. L., Ogura, Y., Esquivel, C. O., Martinez, O. M. and Krams, S. M., IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses. Am. J. Transplant. 2005. 5: 2094-2103.
5. Martin-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A. and Sallusto, F., induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H) I priming. Nat. Immunol. 2004. 5: 1260-1265.
6. Salazar-Mather, T. P., Orange, J. S. and Biron, C. A., Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J. Exp. Med. 1998. 187: 1-14.
7. Vitale, M., Della Chiesa, M., Carlomagno, S., Pende, D., Arico, M., Moretta, L. and Moretta, A., NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 2005. 106: 566-571.
8. Gerosa, F., Baldani-Guerra, B., Nisii, C., Marchesini, V., Carra, G. and Trinchieri, G., Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 2002. 195: 327-333.
9. Piccioli, D., Sbrana, S., Melandri, E. and Valiante, N. M., Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 2002. 195: 335-341.
10. Munz, C., Steinman, R. M. and Fujii, S., Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J. Exp. Med. 2005. 202: 203-207.
11. Bottino, C., Castriconi, R., Moretta, L. and Moretta, A., Cellular ligands of activating NK receptors. Trends Immunol. 2005. 26: 221-226.
12. Moretta, L., Bottino, C., Pende, D., Vitale, M., Mingari, M. C. and Moretta, A., Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis. Immunol. Lett. 2005. 100: 7-13.
13. Cantoni, C., Bottino, C., Vitale, M., Pessino, A., Augugliaro, R., Malaspina, A., Parolini, S. et al., NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J. Exp. Med. 1999. 189: 787-796.
14. Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R. and Moretta, A., Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med. 1998. 188: 953-960.
15. Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E. et al., Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 1999. 190: 1505-1516.
16. Sivori, S., Parolini, S., Marcenaro, E., Castriconi, R., Pende, D., Millo, R. and Moretta, A., Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines. J. Neuroimmunol. 2000. 107: 220-225.
17. Neville, M. J. and Campbell, R. D., A new member of the Ig superfamily and a V-ATPase G subunit are among the predicted products of novel genes close to the TNF locus in the human MHC. J. Immumol. 1999. 162: 4745-4754.
18. Arnon, T. I., Lev, M., Katz, G., Chernobrov, Y., Porgador, A. and Mandelboim, O., Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 2001. 31: 2680-2689.
19. Arnon, T. I, Achdout, H., Levi, O., Markel, G., Saleh, N., Katz, G., Gazit, R. et al., Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat. Immunol. 2005. 6: 515-523.
20. Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M. and Munz, C., Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 2002. 195: 343-351.
21. Spaggiari, G. M., Carosio, R., Pende, D., Marcenaro, S., Rivera, P., Zocchi, M. R., Moretta, L. and Poggi, A., NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur. J. Immunol. 2001. 31: 1656-1665.
22. Hollyoake, M., Campbell, R. D. and Aguado, B., NKp30 (NCR3) is a pseudogene in 12 inbred and wild mouse strains, but an expressed gene in Mus caroli. Mol. Biol. Evol. 2005. 22: 1661-1672.
23. Hsieh, C. L., Ogura, Y., Obara, H., Ali, U. A., Rodriguez, G. M., Nepomuceno, R. R., Martinez, O. M. and Krams, S. M., Identification, cloning, and characterization of a novel rat natural killer receptor, RNKP30: a molecule expressed in liver allografts. Transplantation 2004. 77: 121-128.
24. Backman-Petersson, E., Miller, J. R., Hollyoake, M., Aguado, B. and Butcher, G. W., Molecular characterization of the novel rat NK receptor 1C7. Eur. J. Immunol. 2003. 33: 342-351.
25. Westgaard, I. H., Berg, S. F., Vaage, J. T., Wang, L. L., Yokoyama, W. M., Dissen, E. and Fossum, S., Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta. J. Leukoc. Biol. 2004. 76: 1200-1206.
26. Cooper, M. A., Fehniger, T. A. and Caligiuri, M. A., The biology of human natural killer-cell subsets. Trends Immunol. 2001. 22: 633-640.
27. Ferlazzo, G., Thomas, D., Lin, S. L., Goodman, K., Morandi, B., Muller, W.A., Moretta, A. and Munz, C., The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 2004. 172: 1455-1462.
28. Vermijlen, D., Seynaeve, C., Luo, D., Kruhoffer, M., Eizirik, D. L., Orntoft, T. F. and Wisse, E., High-density oligonucleotide array analysis reveals extensive differences between freshly isolated blood and hepatic natural killer cells. Eur. J. Immunol. 2004. 34: 2529-2540.
29. Vermijlen, D., Luo, D., Froelich, C. J., Medema, J. P., Kummer, J. A., Willems, E., Braet, F. and Wisse, E., Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway. J. Leukoc. Biol. 2002. 72: 668-676.
30. Guma, M., Angulo, A., Vilches, C., Gomez-Lozano, N., Malats, N. and Lopez-Botet, M., Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004. 104: 3664-3671.
31. De Maria, A., Fogli, M., Costa, P., Murdaca, G., Puppo, F., Mavilio, D., Moretta, A. and Moretta, L., The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur. J. Immunol. 2003. 33: 2410-2418.
32. Costello, R. T., Sivori, S., Marcenaro, E., Lafage-Pochitaloff, M., Mozziconacci, M. J., Reviron, D., Gastaut, J. A. et al., Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 2002. 99: 3661-3667
33. Groh, V., Wu, J., Yee, C. and Spies, T., Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002. 419: 734-738.
34. Ogasawara, K., Hamerman, J. A., Hsin, H., Chikuma, S., Bour-Jordan, H., Chen, T., Pertel, T. et al., Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 2003. 18: 41-51.
35. Castriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R. et al., Transforming growth factor {beta} inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells. Proc. Natl. Acad. Sci. USA 2003. 100: 4120-4125.
36. Maier, S., Tertilt, C., Chambron, N., Gerauer, K, Huser, N., Heidecke, C.D. and Pfeffer, K., Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat. Med. 2001. 7: 557-562.
37. Uehara, S., Chase, C. M., Kitchens, W. H., Rose, H. S., Colvin, R. B., Russell, P. S. and Madsen, J. C., NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J. Immunol. 2005. 175: 3424-3430.
38. Dokun, A. O., Kim, S., Smith, H. R., Kang, H. S., Chu, D. T. and Yokoyama, W. M., Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2001. 2: 951-956.
39. Inngjerdingen, M., Rolstad, B. and Ryan, J. C., Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12. J. Immunol. 2003. 171: 2889-2895.
40. Inngjerdingen, M., Damaj, B. and Maghazachi, A. A., Expression and regulation of chemokine receptors in human natural killer cells. Blood 2001. 97: 367-375.
41. Ogura, Y., Martinez, O. M., Villanueva, J. C., Tait, J. F., Strauss, H. W., Higgins, J. P. T., Tanaka, K. et al., Apoptosis and Allograft Rejection in the Absence of CD8+ T Cells. Transplantation 2001. 71: 1827-1834.
42. Ryan, J. C., Niemi, E.C. and Nakamura, M.C., Functional analysis of natural killer cell receptors in the RNK-16 rat leukemic cell line. In Cambell, K. S. and Colonna, M. (Eds.) Natural Killer Cell Protocols. Humana Press, Totowa 1999, pp 283-295.
43. Matzinger, P., The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods 1991. 145: 185-192.